Full Text
HTA238 Oncological Combination Therapies in the Context of the Early Benefit Assessment According to AMNOG: Status Quo and Quo Vadis

Abstract

Authors

N. Fisenkci Y.B. Böhler

Back to Volume 26, Supplemental Issue 12S
Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now

×